BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bando Y, Toyama H, Kanehara H, Hisada A, Okafuji K, Toya D, Tanaka N. Switching from atorvastatin to rosuvastatin lowers small, dense low-density lipoprotein cholesterol levels in Japanese hypercholesterolemic patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 2016;111:66-73. [PMID: 26589368 DOI: 10.1016/j.diabres.2015.10.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Bando Y, Tohyama H, Aoki K, Kanehara H, Hisada A, Okafuji K, Toya D. Ipragliflozin lowers small, dense low-density lipoprotein cholesterol levels in Japanese patients with type 2 diabetes mellitus. J Clin Transl Endocrinol 2016;6:1-7. [PMID: 29067237 DOI: 10.1016/j.jcte.2016.06.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
2 Koizumi T, Kaneda H, Komiyama N, Inoue I, Muramatsu T, Nakajima K. Lipoprotein Profiles before Heparin Administration in Patients with or without Coronary Thrombosis Following Atherosclerosis. Ann Vasc Dis 2021;14:31-8. [PMID: 33786097 DOI: 10.3400/avd.oa.20-00146] [Reference Citation Analysis]
3 Zhang L, Zhang S, Yu Y, Jiang H, Ge J. Efficacy and safety of rosuvastatin vs. atorvastatin in lowering LDL cholesterol : A meta-analysis of trials with East Asian populations. Herz 2020;45:594-602. [PMID: 30483816 DOI: 10.1007/s00059-018-4767-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
4 Gerber PA, Nikolic D, Rizzo M. Small, dense LDL: an update. Curr Opin Cardiol 2017;32:454-9. [PMID: 28426445 DOI: 10.1097/HCO.0000000000000410] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]